Elliptocytosis 2: genes and variants
Explore variant evidence for Elliptocytosis 2 across 2 analyzed proteins (SPTA1, SPTB). Linked ClinVar records include 6 pathogenic or likely pathogenic variants, 64 variants of uncertain significance and 57 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Elliptocytosis 2
SPTA1: Spectrin alpha chain, erythrocytic 1
It forms the alpha-spectrin lattice underlying the red-blood-cell membrane and provides elasticity needed to survive repeated passage through the circulation. Pathogenic variants cause hereditary elliptocytosis, hereditary spherocytosis, or severe hereditary pyropoikilocytosis.
3 ClinVar pathogenic / likely pathogenic and 105 uncertain variants in SPTA1 have source records linked to Elliptocytosis 2. Association strength is not clinical gene validity.
SPTB: Spectrin beta chain, erythrocytic
It contributes beta-spectrin to the red-blood-cell membrane skeleton, linking the lipid bilayer to actin and ankyrin complexes. Pathogenic variants can cause hereditary spherocytosis, elliptocytosis, or related congenital hemolytic anemia.
3 ClinVar pathogenic / likely pathogenic and 16 uncertain variants in SPTB have source records linked to Elliptocytosis 2. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Elliptocytosis 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SPTA1 R28C | 28 | Pathogenic / likely pathogenic (★★) | |
| SPTB E2075G | 2075 | Spectrin 17 | Pathogenic / likely pathogenic (★★) |
| SPTA1 R45S | 45 | Pathogenic / likely pathogenic | |
| SPTB R2064P | 2064 | Spectrin 17 | Pathogenic / likely pathogenic |
| SPTB A2018G | 2018 | Spectrin 17 | Pathogenic / likely pathogenic |
| SPTA1 R41W | 41 | Pathogenic / likely pathogenic |
Same protein, different disease
- Hereditary spherocytosis also has ClinVar records linked to SPTB variants; they fall mostly in different places as the Elliptocytosis 2 variants (7 pathogenic / likely pathogenic).
Diseases related to Elliptocytosis 2
- Hereditary spherocytosis, also linked to SPTA1 and SPTB
Frequently asked questions
Which genes have records linked to Elliptocytosis 2?
This view contains 2 analyzed proteins: SPTA1, SPTB. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 6 pathogenic or likely pathogenic variants, 64 variants of uncertain significance and 57 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 148 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center